| Results summary | View all lists in GO:BiolProc | View all genes in G03A.profile.u50 |
anatomical structure development The biological process whose specific outcome is the progression of an anatomical structure from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure, whatever form that may be including its natural destruction. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome. enrichment: 1.72-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 210395_X_AT | MYL4 | D | myosin, light chain 4, alkali; atrial, embryonic | ||||||||||
| 214571_AT | FGF3 | G | D | C | S | fibroblast growth factor 3 (murine mammary tumor virus integration site (v-int-2) oncogene homolog) | |||||||
| 210512_S_AT | VEGFA | G | D | X | S | vascular endothelial growth factor A | |||||||
| 200924_S_AT | SLC3A2 | T | E | solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 | |||||||||
| 220266_S_AT | KLF4 | G | D | R | Kruppel-like factor 4 (gut) | ||||||||
| 205842_S_AT | JAK2 | D | P | S | Janus kinase 2 (a protein tyrosine kinase) | ||||||||
| 205549_AT | PCP4 | D | Purkinje cell protein 4 | ||||||||||
| 203140_AT | BCL6 | G | D | X | R | C | S | B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||||
| 212501_AT | CEBPB | G | D | X | P | R | CCAAT/enhancer binding protein (C/EBP), beta | ||||||
| 211421_S_AT | RET | D | P | C | S | ret proto-oncogene | |||||||
| 203977_AT | TAZ | D | tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome) | ||||||||||
| 206115_AT | EGR3 | D | R | C | early growth response 3 | ||||||||